If the answer is yes, then consider the Newton Fund:
The Newton Fund is a £375 million fund operated by the UK’s Department for Business, Innovation and Skills. It provides £75 million a year for five years, starting from 2014/15, and the intention is that UK funding is matched by partner countries. Through the Newton Fund, the UK will use its strength in research and innovation to promote the economic development and social welfare of partner countries. By working together on bi-lateral and multi-lateral programmes with a research and innovation focus, the UK will build strong, sustainable, systemic relationships with partner countries.
The Newton Fund is part of the UK’s Official Development Assistance (ODA) commitment. The first years of the Fund will cover 15 countries: China, India, Brazil, South Africa, Mexico, Colombia, Chile, Turkey, Malaysia, Thailand, Vietnam, Indonesia, Philippines, Egypt and Kazakhstan.
Find out about current opportunities, which include:
-
ESRC-NRF Newton Call for Collaborative Research Urban Transformations in South Africa
- Kâtip Çelebi (research co-operation between Turkey and the UK)
If you are interested in these or other international funding streams, please contact Emily Cieciura, Research Facilitator – EU and International or the Funding Development Officer for your Faculty











Congratulation on newly published systematic review
Equitable Partnerships in Global Health Research
New Nepal-based paper published last week
Congratulation to HEMS colleagues on their new book!
Book edited by BU academics published
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease